Page last updated: 2024-08-24

valsartan and Diabetes Mellitus, Type 1

valsartan has been researched along with Diabetes Mellitus, Type 1 in 11 studies

Research

Studies (11)

Timeframe	Studies, this research(%)	All Research%
pre-1990	0 (0.00)	18.7374
1990's	0 (0.00)	18.2507
2000's	6 (54.55)	29.6817
2010's	4 (36.36)	24.3611
2020's	1 (9.09)	2.80

Authors

Authors	Studies
Keshawy, MM; Makary, S; Tawfik, MK	1
Janež, A; Janić, M; Kanc, K; Lunder, M; Šabovič, M; Savić, V	1
Boncelj, M; Eržen, B; Janež, A; Janić, M; Kanc, K; Lunder, M; Šabović, M; Savić, V	1
Amini, M; Gheissari, A; Javanmard, SH; Khalili, N; Shirzadi, R	1
Chang, KC; Ha, YM; Kang, YJ; Kim, HJ; Park, EJ; Park, SW	1
Crikelair, N; Lastra, G; Levy, DG; Rocha, R; Seifu, Y; Sowers, JR	1
Chan, P; Cheng, JT; Liu, IM; Tzeng, TF; Wong, KL; Yang, TL	1
Andersen, S; Jacobsen, P; Jensen, BR; Parving, HH	1
Hausberg, M; Hohage, H; Kosch, M	1
Cheng, ZJ; Luft, FC; Mervaala, EM; Muller, D; Nurminen, K; Park, JK; Ruskoaho, H; Tikkanen, I; Vapaatalo, H; Vaskonen, T	1
Shimoni, Y	1

Trials

2 trial(s) available for valsartan and Diabetes Mellitus, Type 1

Article	Year
Initial combination therapy compared with monotherapy in diabetic hypertensive patients. Journal of clinical hypertension (Greenwich, Conn.), 2008, Volume: 10, Issue:9 Topics: Aged; Angiotensin II Type 1 Receptor Blockers; Antihypertensive Agents; Blood Glucose; Blood Pressure; C-Reactive Protein; Diabetes Mellitus, Type 1; Diabetes Mellitus, Type 2; Diuretics; Dose-Response Relationship, Drug; Double-Blind Method; Drug Therapy, Combination; Female; Follow-Up Studies; Humans; Hydrochlorothiazide; Hypertension; Hypoglycemic Agents; Male; Middle Aged; Severity of Illness Index; Tetrazoles; Treatment Outcome; Valine; Valsartan	2008
Additive effect of ACE inhibition and angiotensin II receptor blockade in type I diabetic patients with diabetic nephropathy. Journal of the American Society of Nephrology : JASN, 2003, Volume: 14, Issue:4 Topics: Adult; Albuminuria; Angiotensin Receptor Antagonists; Angiotensin-Converting Enzyme Inhibitors; Antihypertensive Agents; Benzazepines; Blood Pressure; Cross-Over Studies; Diabetes Mellitus, Type 1; Diabetic Nephropathies; Double-Blind Method; Drug Synergism; Female; Glomerular Filtration Rate; Humans; Male; Middle Aged; Tetrazoles; Valine; Valsartan	2003

Article

Year

Initial combination therapy compared with monotherapy in diabetic hypertensive patients.

Journal of clinical hypertension (Greenwich, Conn.), 2008, Volume: 10, Issue:9

Topics: Aged; Angiotensin II Type 1 Receptor Blockers; Antihypertensive Agents; Blood Glucose; Blood Pressure; C-Reactive Protein; Diabetes Mellitus, Type 1; Diabetes Mellitus, Type 2; Diuretics; Dose-Response Relationship, Drug; Double-Blind Method; Drug Therapy, Combination; Female; Follow-Up Studies; Humans; Hydrochlorothiazide; Hypertension; Hypoglycemic Agents; Male; Middle Aged; Severity of Illness Index; Tetrazoles; Treatment Outcome; Valine; Valsartan

2008

Additive effect of ACE inhibition and angiotensin II receptor blockade in type I diabetic patients with diabetic nephropathy.

Journal of the American Society of Nephrology : JASN, 2003, Volume: 14, Issue:4

Topics: Adult; Albuminuria; Angiotensin Receptor Antagonists; Angiotensin-Converting Enzyme Inhibitors; Antihypertensive Agents; Benzazepines; Blood Pressure; Cross-Over Studies; Diabetes Mellitus, Type 1; Diabetic Nephropathies; Double-Blind Method; Drug Synergism; Female; Glomerular Filtration Rate; Humans; Male; Middle Aged; Tetrazoles; Valine; Valsartan

2003

Other Studies

9 other study(ies) available for valsartan and Diabetes Mellitus, Type 1

Article	Year
Blocking angiotensin 2 receptor attenuates diabetic nephropathy via mitigating ANGPTL2/TL4/NF-κB expression. Molecular biology reports, 2021, Volume: 48, Issue:9 Topics: Angiopoietin-Like Protein 2; Angiotensin II; Angiotensin Receptor Antagonists; Animals; Diabetes Mellitus, Experimental; Diabetes Mellitus, Type 1; Diabetic Nephropathies; Gene Expression; Kidney; Male; NF-kappa B; Protective Agents; Rats; Rats, Wistar; Real-Time Polymerase Chain Reaction; Receptor, Angiotensin, Type 2; RNA, Messenger; Streptozocin; Toll-Like Receptor 4; Treatment Outcome; Valsartan	2021
Very low-dose fluvastatin-valsartan combination decreases parameters of inflammation and oxidative stress in patients with type 1 diabetes mellitus. Diabetes research and clinical practice, 2017, Volume: 127 Topics: Adult; Diabetes Mellitus, Type 1; Double-Blind Method; Fatty Acids, Monounsaturated; Female; Fluvastatin; Humans; Hydroxymethylglutaryl-CoA Reductase Inhibitors; Indoles; Inflammation; Male; Oxidative Stress; Valsartan	2017
Improvement of arterial wall characteristics by the low-dose fluvastatin and valsartan combination in type 1 diabetes mellitus patients. Diabetes & vascular disease research, 2013, Volume: 10, Issue:5 Topics: Adult; Angiotensin II Type 1 Receptor Blockers; Anticholesteremic Agents; Blood Pressure; Carotid Arteries; Diabetes Mellitus, Type 1; Drug Therapy, Combination; Fatty Acids, Monounsaturated; Female; Fluvastatin; Humans; Indoles; Male; Middle Aged; Tetrazoles; Treatment Outcome; Valine; Valsartan	2013
Lowering effect of valsartan on fetuin-A in type 1 diabetes mellitus. Iranian journal of kidney diseases, 2013, Volume: 7, Issue:6 Topics: Adult; Albuminuria; alpha-2-HS-Glycoprotein; Angiotensin II Type 1 Receptor Blockers; Cholesterol, LDL; Creatine; Cross-Sectional Studies; Diabetes Mellitus, Type 1; Female; Glycated Hemoglobin; Humans; Male; Renin-Angiotensin System; Tetrazoles; Valine; Valsartan; Young Adult	2013
Valsartan independent of AT₁ receptor inhibits tissue factor, TLR-2 and -4 expression by regulation of Egr-1 through activation of AMPK in diabetic conditions. Journal of cellular and molecular medicine, 2014, Volume: 18, Issue:10 Topics: AMP-Activated Protein Kinases; Angiotensin II Type 1 Receptor Blockers; Animals; Blotting, Western; Cells, Cultured; Chromatin Immunoprecipitation; Diabetes Mellitus, Experimental; Diabetes Mellitus, Type 1; Early Growth Response Protein 1; Enzyme-Linked Immunosorbent Assay; Gene Expression Regulation; Glucose Tolerance Test; Humans; Male; Mice; Mice, Inbred C57BL; Monocytes; Receptor, Angiotensin, Type 1; RNA, Small Interfering; Tetrazoles; Thromboplastin; Toll-Like Receptor 2; Toll-Like Receptor 4; Valine; Valsartan	2014
Antihyperglycemic action of angiotensin II receptor antagonist, valsartan, in streptozotocin-induced diabetic rats. Journal of hypertension, 2003, Volume: 21, Issue:4 Topics: Angiotensin II Type 1 Receptor Blockers; Animals; Antihypertensive Agents; Blood Glucose; Calcium Channel Blockers; Diabetes Mellitus, Experimental; Diabetes Mellitus, Type 1; Disease Models, Animal; Gene Expression; Glucose Tolerance Test; Glucose Transporter Type 4; Hyperglycemia; Liver; Male; Monosaccharide Transport Proteins; Muscle Proteins; Muscle, Skeletal; Nicorandil; Nifedipine; Phosphoenolpyruvate Carboxykinase (GTP); Rats; Rats, Wistar; RNA, Messenger; Saralasin; Tetrazoles; Valine; Valsartan	2003
[Hypertension and diabetic nephropathy, a dangerous duo]. Medizinische Klinik (Munich, Germany : 1983), 2005, Nov-15, Volume: 100, Issue:11 Topics: Aged; Angiotensin II Type 1 Receptor Blockers; Angiotensin-Converting Enzyme Inhibitors; Antihypertensive Agents; Clinical Trials as Topic; Diabetes Mellitus, Type 1; Diabetes Mellitus, Type 2; Diabetic Nephropathies; Diuretics; Drug Therapy, Combination; Enalapril; Glomerular Filtration Rate; Humans; Hypertension; Male; Metabolic Syndrome; Ramipril; Tetrazoles; Valine; Valsartan	2005
Endothelial dysfunction and salt-sensitive hypertension in spontaneously diabetic Goto-Kakizaki rats. Hypertension (Dallas, Tex. : 1979), 2001, Volume: 37, Issue:2 Pt 2 Topics: Acetylcholine; Angiotensin Receptor Antagonists; Animals; Blood Pressure; Diabetes Mellitus, Type 1; Endothelium, Vascular; Heart Rate; Hypertension; In Vitro Techniques; Mesenteric Arteries; Neprilysin; Nitroprusside; Norepinephrine; Peptidyl-Dipeptidase A; Rats; Rats, Wistar; Receptor, Angiotensin, Type 1; Receptor, Angiotensin, Type 2; Receptors, Angiotensin; Sodium, Dietary; Tetrazoles; Valine; Valsartan	2001
Inhibition of the formation or action of angiotensin II reverses attenuated K+ currents in type 1 and type 2 diabetes. The Journal of physiology, 2001, Nov-15, Volume: 537, Issue:Pt 1 Topics: Action Potentials; Angiotensin II; Angiotensin Receptor Antagonists; Angiotensin-Converting Enzyme Inhibitors; Animals; Carrier Proteins; Diabetes Mellitus, Experimental; Diabetes Mellitus, Type 1; Diabetes Mellitus, Type 2; Electric Conductivity; Isoquinolines; Mutation; Potassium Channels; Quinapril; Rats; Rats, Sprague-Dawley; Reaction Time; Receptor, Angiotensin, Type 2; Receptors, Cell Surface; Receptors, Leptin; Saralasin; Tetrahydroisoquinolines; Tetrazoles; Valine; Valsartan	2001